Literature DB >> 31464676

The kaleidoscope of neurological manifestations in primary Sjögren's syndrome.

Alessia Alunno1, Francesco Carubbi2, Elena Bartoloni1, Paola Cipriani3, Roberto Giacomelli3, Roberto Gerli4.   

Abstract

Neurologic involvement is a common extraglandular manifestation of primary Sjögren's syndrome (pSS), is varied and can be divided anatomically into 3 categories: central nervous system, peripheral neuropathies and autonomous nervous system manifestations. According to different study cohorts, neurological manifestations can occur in 18-45% of pSS patients, with the peripheral nervous system being the most frequent site of involvement compared to the central nervous system and autonomic system. Some neurologic complications share convergent pathophysiology, although the pathological basis of other conditions, namely cognitive impairment in pSS, is less clear. The heterogeneity of neurologic manifestations in pSS complicates the diagnosis and approach to treatment, which should be directed toward the underlying neuro-pathologic mechanism. The diagnosis and treatment of these manifestations must be optimised in order to avoid severe disability. However, for the majority of the complications, evidence for treatment efficacy is limited and requires further investigation.

Entities:  

Mesh:

Year:  2019        PMID: 31464676

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  9 in total

1.  Cerebellar Atrophy Associated with Primary Sjögren's Syndrome: Diagnosis, Therapy, and Virtual Reality Rehabilitation: A Case Report.

Authors:  Emanuele Lo Voi; Giorgio Carmelo Basile; Alessia Bramanti; Giuseppe Paladina; Annalisa Militi; Daniele Bruschetta; Angelo Alito; Filippo Cavallaro; Salvatore Bertino; Demetrio Milardi
Journal:  Innov Clin Neurosci       Date:  2021 Jul-Sep

2.  Sjogren Syndrome-Associated Autonomic Neuropathy.

Authors:  Nourhan Chaaban; Timothy Shaver; Shilpa Kshatriya
Journal:  Cureus       Date:  2022-06-01

3.  Acute polyneuropathy as the main manifestation of primary Sjogren's syndrome: A case report.

Authors:  Arsh Haj Mohamad Ebrahim Ketabforoush; Nahid Abbasi Khoshsirat; Arman Maghoul; Matineh Nirouei; Elahe Dolatshahi
Journal:  Clin Case Rep       Date:  2022-05-09

4.  Pulmonary Involvement in a Mouse Model of Sjögren's Syndrome Induced by STING Activation.

Authors:  Joanna Papinska; Harini Bagavant; Grzegorz B Gmyrek; Umesh S Deshmukh
Journal:  Int J Mol Sci       Date:  2020-06-25       Impact factor: 5.923

5.  Peripheral Nervous System Involvement in Sjögren's Syndrome: Analysis of a Cohort From the Italian Research Group on Sjögren's Syndrome.

Authors:  Giacomo Cafaro; Carlo Perricone; Francesco Carubbi; Chiara Baldini; Luca Quartuccio; Roberta Priori; Onorina Berardicurti; Francesco Ferro; Saviana Gandolfo; Angelica Gattamelata; Roberto Giacomelli; Salvatore De Vita; Roberto Gerli; Elena Bartoloni
Journal:  Front Immunol       Date:  2021-03-24       Impact factor: 7.561

6.  Metformin Use Was Associated With Reduced Risk of Incidental Sjögren's Syndrome in Patients With Type 2 Diabetes: A Population-Based Cohort Study.

Authors:  Cheng-You Wang; Jung-Nien Lai; Chin-Hsiu Liu; Kai-Chieh Hu; Kai-Lun Sheu; James Cheng-Chung Wei
Journal:  Front Med (Lausanne)       Date:  2022-01-12

Review 7.  Headache and immunological/autoimmune disorders: a comprehensive review of available epidemiological evidence with insights on potential underlying mechanisms.

Authors:  Leonardo Biscetti; Gioacchino De Vanna; Elena Cresta; Ilenia Corbelli; Lorenzo Gaetani; Letizia Cupini; Paolo Calabresi; Paola Sarchielli
Journal:  J Neuroinflammation       Date:  2021-11-08       Impact factor: 8.322

8.  Progressive sensory ataxia and breast implant rupture, an uncommon presentation of a debated concept: a case report.

Authors:  Sofie Van Assche; Heleen Parmentier; Gaelle Varkas; Isabelle Peene; Sarah Herdewyn
Journal:  BMC Neurol       Date:  2022-09-24       Impact factor: 2.903

9.  Sjögren's syndrome.

Authors:  Fiona André; Barbara C Böckle
Journal:  J Dtsch Dermatol Ges       Date:  2022-07-01       Impact factor: 5.231

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.